This topic contains a solution. Click here to go to the answer

Author Question: This experimental design (R) X Y2 (R) - Y2 is recommended for studies in which a. ... (Read 63 times)

mcmcdaniel

  • Hero Member
  • *****
  • Posts: 550
This experimental design
 
  (R)
  X
  Y2
  (R)
  -
  Y2
 
  is recommended for studies in which
 
  a. pretest reactivity is likely to occur.
  c. a large sample is available.
  b. no control group is available.
  d. only a small sample is available.

Question 2

After an experiment was in progress, a researcher learned that the experimental group had a more experienced teacher than did the control group. Should the researcher mention this fact in the research report?
 
  a. Yes, any factor which might affect the internal validity of the experiment should be reported.
  b. No, it is not necessary for the reader to know all the details about problems which arise during the course of a study



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

scrocafella

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

A

Answer to Question 2

ANS: A




mcmcdaniel

  • Member
  • Posts: 550
Reply 2 on: Jun 20, 2018
:D TYSM


duy1981999

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

For a complete list of videos, visit our video library